Author Question: Assume that we asked 20 subjects to participate in a smoking cessation study. We recorded their ... (Read 93 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
Assume that we asked 20 subjects to participate in a smoking cessation study. We recorded their craving for a cigarette before and after applying a nicotine patch. One reason we might want to use a distribution-free test is because
 
  a. we have too few subjects for a parametric test.
  b. there are some outliers that we don't want to have undue influence on the results.
  c. the data are normally distributed.
  d. the subjects are all male.

Question 2

When we have relatively large sample sizes, the distribution-free tests for comparing two groups or sets of data discussed in the text have
 
  a. a chi-square approximation.
  b. a normal approximation.
  c. no solution.
  d. problems.



prumorgan

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

B

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library